Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Cancer Res ; 70(6): 2359-67, 2010 Mar 15.
Article in English | MEDLINE | ID: mdl-20215501

ABSTRACT

Cigarette smoking is the major cause for lung cancer, but genetic factors also affect susceptibility. We studied families that included multiple relatives affected by lung cancer. Results from linkage analysis showed strong evidence that a region of chromosome 6q affects lung cancer risk. To characterize the effects that this region of chromosome 6q region has on lung cancer risk, we identified a haplotype that segregated with lung cancer. We then performed Cox regression analysis to estimate the differential effects that smoking behaviors have on lung cancer risk according to whether each individual carried a risk-associated haplotype or could not be classified and was assigned unknown haplotypic status. We divided smoking exposures into never smokers, light smokers (<20 pack-years), moderate smokers (20 to <40 pack-years), and heavy smokers (>or=40 pack-years). Comparing results according to smoking behavior stratified by carrier status, compared with never smokers, there was weakly increasing risk for increasing smoking behaviors, with the hazards ratios being 3.44, 4.91, and 5.18, respectively, for light, moderate, or heavy smokers, whereas among the individuals from families without the risk haplotype, the risks associated with smoking increased strongly with exposure, the hazards ratios being, respectively, 4.25, 9.17, and 11.89 for light, moderate, and heavy smokers. The never smoking carriers had a 4.71-fold higher risk than the never smoking individuals without known risk haplotypes. These results identify a region of chromosome 6q that increases risk for lung cancer and that confers particularly higher risks to never and light smokers.


Subject(s)
Chromosomes, Human, Pair 6 , Lung Neoplasms/genetics , Smoking/genetics , Female , Genetic Linkage , Genetic Predisposition to Disease , Haplotypes , Humans , Lung Neoplasms/etiology , Male , Smoking/adverse effects
2.
Cancer Res ; 69(19): 7844-50, 2009 Oct 01.
Article in English | MEDLINE | ID: mdl-19789337

ABSTRACT

Recent genome-wide association studies have linked the chromosome 15q24-25.1 locus to nicotine addiction and lung cancer susceptibility. To refine the 15q24-25.1 locus, we performed a haplotype-based association analysis of 194 familial lung cases and 219 cancer-free controls from the Genetic Epidemiology of Lung Cancer Consortium (GELCC) collection, and used proliferation and apoptosis analyses to determine which gene(s) in the 15q24-25.1 locus mediates effects on lung cancer cell growth in vitro. We identified two distinct subregions, hapL (P = 3.20 x 10(-6)) and hapN (P = 1.51 x 10(-6)), which were significantly associated with familial lung cancer. hapL encompasses IREB2, LOC123688, and PSMA4, and hapN encompasses the three nicotinic acetylcholine receptor subunit genes CHRNA5, CHRNA3, and CHRNB4. Examination of the genes around hapL revealed that PSMA4 plays a role in promoting cancer cell proliferation. PSMA4 mRNA levels were increased in lung tumors compared with normal lung tissues. Down-regulation of PSMA4 expression decreased proteasome activity and induced apoptosis. Proteasome dysfunction leads to many diseases including cancer, and drugs that inhibit proteasome activity show promise as a form of cancer treatment. Genes around hapN were also investigated, but did not show any direct effect on lung cancer cell proliferation. We concluded that PSMA4 is a strong candidate mediator of lung cancer cell growth, and may directly affect lung cancer susceptibility through its modulation of cell proliferation and apoptosis.


Subject(s)
Carcinoma, Non-Small-Cell Lung/genetics , Chromosomes, Human, Pair 15 , Lung Neoplasms/genetics , Cell Growth Processes/genetics , Cell Line, Tumor , Genetic Predisposition to Disease , Haplotypes , Humans , Lung Neoplasms/pathology , Physical Chromosome Mapping , Proteasome Endopeptidase Complex/genetics
3.
Clin Cancer Res ; 15(8): 2666-74, 2009 Apr 15.
Article in English | MEDLINE | ID: mdl-19351763

ABSTRACT

PURPOSE: We have previously mapped a major susceptibility locus influencing familial lung cancer risk to chromosome 6q23-25. However, the causal gene at this locus remains undetermined. In this study, we further refined this locus to identify a single candidate gene, by fine mapping using microsatellite markers and association studies using high-density single nucleotide polymorphisms (SNP). EXPERIMENTAL DESIGN: Six multigenerational families with five or more affected members were chosen for fine-mapping the 6q linkage region using microsatellite markers. For association mapping, we genotyped 24 6q-linked cases and 72 unrelated noncancer controls from the Genetic Epidemiology of Lung Cancer Consortium resources using the Affymetrix 500K chipset. Significant associations were validated in two independent familial lung cancer populations: 226 familial lung cases and 313 controls from the Genetic Epidemiology of Lung Cancer Consortium, and 154 familial cases and 325 controls from Mayo Clinic. Each familial case was chosen from one high-risk lung cancer family that has three or more affected members. RESULTS: A region-wide scan across 6q23-25 found significant association between lung cancer susceptibility and three single nucleotide polymorphisms in the first intron of the RGS17 gene. This association was further confirmed in two independent familial lung cancer populations. By quantitative real-time PCR analysis of matched tumor and normal human tissues, we found that RGS17 transcript accumulation is highly and consistently increased in sporadic lung cancers. Human lung tumor cell proliferation and tumorigenesis in nude mice are inhibited upon knockdown of RGS17 levels. CONCLUSION: RGS17 is a major candidate for the familial lung cancer susceptibility locus on chromosome 6q23-25.


Subject(s)
Chromosomes, Human, Pair 6/genetics , Genetic Predisposition to Disease , Lung Neoplasms/genetics , RGS Proteins/genetics , Aged , Animals , Cell Line, Tumor , Chromosome Mapping , Female , Gene Knockdown Techniques , Genotype , Haplotypes/genetics , Humans , Lung/pathology , Lung Neoplasms/epidemiology , Lung Neoplasms/metabolism , Male , Mice , Mice, Nude , Microsatellite Repeats/genetics , Middle Aged , Oligonucleotide Array Sequence Analysis , Polymorphism, Single Nucleotide/genetics , RGS Proteins/metabolism , RNA, Small Interfering/metabolism , Transplantation, Heterologous/pathology
4.
J Natl Cancer Inst ; 100(18): 1326-30, 2008 Sep 17.
Article in English | MEDLINE | ID: mdl-18780872

ABSTRACT

Three recent genome-wide association studies identified associations between markers in the chromosomal region 15q24-25.1 and the risk of lung cancer. We conducted a genome-wide association analysis to investigate associations between single-nucleotide polymorphisms (SNPs) and the risk of lung cancer, in which we used blood DNA from 194 case patients with familial lung cancer and 219 cancer-free control subjects. We identified associations between common sequence variants at 15q24-25.1 (that spanned LOC123688 [a hypothetical gene], PSMA4, CHRNA3, CHRNA5, and CHRNB4) and lung cancer. The risk of lung cancer was more than fivefold higher among those subjects who had both a family history of lung cancer and two copies of high-risk alleles rs8034191 (odds ratio [OR] = 7.20, 95% confidence interval [CI] = 2.21 to 23.37) or rs1051730 (OR = 5.67, CI = 2.21 to 14.60, both of which were located in the 15q24-25.1 locus, than among control subjects. Thus, further research to elucidate causal variants in the 15q24-25.1 locus that are associated with lung cancer is warranted.


Subject(s)
Chromosomes, Human, Pair 15 , DNA, Neoplasm/analysis , Lung Neoplasms/genetics , Polymorphism, Single Nucleotide , Case-Control Studies , Chromosomes, Human, Pair 15/genetics , Confounding Factors, Epidemiologic , Genetic Predisposition to Disease , Genotype , Humans , Research Design , Sequence Analysis, DNA , Smoking/adverse effects
5.
Cancer Res ; 67(10): 4665-70, 2007 May 15.
Article in English | MEDLINE | ID: mdl-17510392

ABSTRACT

The use of tyrosine kinase inhibitors (TKI) has yielded great success in treatment of lung adenocarcinomas. However, patients who develop resistance to TKI treatment often acquire a somatic resistance mutation (T790M) located in the catalytic cleft of the epidermal growth factor receptor (EGFR) enzyme. Recently, a report describing EGFR-T790M as a germ-line mutation suggested that this mutation may be associated with inherited susceptibility to lung cancer. Contrary to previous reports, our analysis indicates that the T790M mutation confers increased Y992 and Y1068 phosphorylation levels. In a human bronchial epithelial cell line, overexpression of EGFR-T790M displayed a growth advantage over wild-type (WT) EGFR. We also screened 237 lung cancer family probands, in addition to 45 bronchoalveolar tumors, and found that none of them contained the EGFR-T790M mutation. Our observations show that EGFR-T790M provides a proliferative advantage with respect to WT EGFR and suggest that the enhanced kinase activity of this mutant is the basis for rare cases of inherited susceptibility to lung cancer.


Subject(s)
Alleles , ErbB Receptors/metabolism , Genes, erbB-1 , Lung Neoplasms/enzymology , Lung Neoplasms/genetics , Animals , COS Cells , Chlorocebus aethiops , DNA, Neoplasm/genetics , ErbB Receptors/biosynthesis , ErbB Receptors/genetics , Genetic Predisposition to Disease , Germ-Line Mutation , Humans , Pedigree , Phosphorylation
6.
Cancer Res ; 67(1): 93-9, 2007 Jan 01.
Article in English | MEDLINE | ID: mdl-17210687

ABSTRACT

In this study, we observed loss of heterozygosity (LOH) in human chromosomal fragment 6q25.1 in sporadic lung cancer patients. LOH was observed in 65% of the 26 lung tumors examined and was narrowed down to a 2.2-Mb region. Single-nucleotide polymorphism (SNP) analysis of genes located within this region identified a candidate gene, termed p34. This gene, also designated as ZC3H12D, C6orf95, FLJ46041, or dJ281H8.1, carries an A/G nonsynonymous SNP at codon 106, which alters the amino acid from lysine to arginine. Nearly 73% of heterozygous lung cancer tissues with LOH and the A/G SNP also exhibited loss of the A allele. In vitro clonogenic and in vivo nude mouse studies showed that overexpression of the A allele exerts tumor suppressor function compared with the G allele. p34 is located within a recently mapped human lung cancer susceptibility locus, and association of the p34 A/G SNP was tested among these families. No significant association between the less frequent G allele and lung cancer susceptibility was found. Our results suggest that p34 may be a novel tumor suppressor gene involved in sporadic lung cancer but it seems not to be the candidate familial lung cancer susceptibility gene linked to chromosomal region 6q23-25.


Subject(s)
Chromosomes, Human, Pair 6 , Genes, Tumor Suppressor , Loss of Heterozygosity , Lung Neoplasms/genetics , Alleles , Animals , Base Sequence , Codon , Female , Genetic Predisposition to Disease , Humans , Mice , Mice, Nude , Molecular Sequence Data , Polymorphism, Single Nucleotide
8.
Louisiana; Academic Press; 1981. 653 p.
Monography in English | LILACS, Sec. Est. Saúde SP, SESSP-ISPROD, Sec. Est. Saúde SP, SESSP-ISACERVO | ID: biblio-1072944
SELECTION OF CITATIONS
SEARCH DETAIL
...